# 🧬 CGT 每日情报 (Daily Brief)
> **日期**: 2026-01-17 | **更新时间**: 09:06 (北京时间)
> **监控范围**: Global (In vivo/FDA) & China (NMPA/Biotech)

---

## 🌍 全球前沿 (FDA / In vivo / MNCs)
- `[20:00]` **ImmunityBio 宣布使用无化疗 CD19 CAR-NK 细胞疗法治疗华尔登斯特伦淋巴瘤可达到 15 个月的持久完全缓解**
  <br><small>🇬🇧 *ImmunityBio Announces Durable Complete Response of 15 Months with a Chemotherapy-Free CD19 CAR-NK Cell Therapy in Waldenstrom Lymphoma* [🔗Source](https://news.google.com/rss/articles/CBMimwJBVV95cUxPM01jWmVraFpmS3F6R0NBeFM5bkRjQ01pU1Z4QVFvWk5WaDlDS2wzQW5xZjY4RkFxaFJabzlPSmpkejduM1E0T2FTdVN0WVh2cFotS21kQ1hUX0wyazdHX3NwSTEyR2FEZl9IUlNKd3BVVGJ6NmJVMTE1eDBfUFBJZDJULWZ1NTFPQ0FSZk12cjU3MXc4NzZvOGlXcWdvNEpxNTJ1QndKX1BBUnk5Qkl3aFpZWGtzbVJ3cHlpMVczTFdlWVpOSDR3bFZFeHlaZTZsMmhKMWM5dXVQX2lIVDUtWGUwT2pwUmU3OFRrT01jY3ZwNVlEcVJjM3Bab2ZzY1lqR0NXUGFmSkJYa2VnN1NjYnVLaTJNMENlbERR?oc=5)</small>
- `[20:00]` **ImmunityBio 推进一线 BCG Naive NMIBC 项目，入组人数超出预期，ANKTIVA® Plus BCG 的中期分析结果积极**
  <br><small>🇬🇧 *ImmunityBio Advances First-Line BCG Naive NMIBC Program with Enrollment Exceeding Expectations and Positive Interim Analysis for ANKTIVA® Plus BCG* [🔗Source](https://news.google.com/rss/articles/CBMiqgJBVV95cUxQZ0VaMVBkVUh1UExLc3VLQUtzR2RFOHRBbW9GSk5oLUVERmZNOW4zSkVkdkJzVm9EMVBtUGFlbVhlUFJEU2lzczFSM01nMnhUTHU3OHpMNTdKSTdyRG5zNzk5c29wQXg3bFo5b3FfQW14NUgtbE94X3FNY2ZGWnlSNEJ0MlVuTzBlR1k4bXhNQ1BmZ3V5Z3JfbXBzX2RzcHhRU2NwS3NiZ3NNbU0ydDJTNzk2QXBEMEYtLXJnRjFpNko1cFl4TTAwZGZSQlk0dktCaUh4VHlXQjNhVnFIMDNYUk9vTGlQUS1SSzNMTTNGUmQwbW9RaHZrYXZUT3duS2tERGVGM2hIaUFSdlh4akhmM3MwbllxZThFb0hqcWRyQTVGNHRDQnZXVHR3?oc=5)</small>

---

## 🇨🇳 中国动态 (NMPA / Domestic Players)
- `[08:00]` **280万，华西医院拟转化一项抗衰老CAR-T技术** [🔗阅读原文](https://news.google.com/rss/articles/CBMiR0FVX3lxTE03eFRVckNoT3puZHdLX1FDbXJtajdiOFRKMl9OVl9idlNZNnU1dmp1ejVaMFEwUG10d0puODBxS0V4Rm1WaGpV?oc=5)
- `[05:07]` **2026年中国值得关注的六种药物**
  <br><small>🇬🇧 *Six drugs to watch in China for 2026* [🔗Source](https://news.google.com/rss/articles/CBMigwFBVV95cUxQYTJxMDNGeUNJZlJDM2RhbzFRMlBWdXVHdzYzcFVXZnQzdEZYcDhJVHB4Sl9UODNnWU5jOWVYT0VIZXVwa1FvenZ6SFJiQlh0b0VydFdCYWo2ODFhWlFsYndvNG1fN1k5WUJtUmN1Yms5ZFZmRm1IU3ZNUkpLbTBXSXlKTQ?oc=5)</small>
- `[03:31]` **胰腺癌治疗新突破：多抗原靶向T细胞疗法临床研究展现惊人疗效，为患者带来新希望** [🔗阅读原文](https://news.google.com/rss/articles/CBMiRkFVX3lxTE5lZ2tFVDlGX0JCdG52MUdNRXpTZVRlaVZ5cHh5bzc4THJLbHVMNm9QQWZPbWlFTlhMeUwyeE9zaUYyOWYxeEE?oc=5)
- `[22:38]` **科创板“CAR-T第一股”要来了** [🔗阅读原文](https://news.google.com/rss/articles/CBMihwFBVV95cUxNaGFhejBGWWV6aEtBWGdYaFJSbjROYkxnQnNVVkp0T0tlQ1VDc1gwY2ZpdjFMNmxtOXJfczVTTkp2TGlxVHVfbzhzY1Z1ZE5sZ1AtQllQMDZuRUZlMTNzZG5JY2wxODFmNFRaMjlLVHBld3l5QlVvM1pTMzNQZzZiUF91WDRtM0E?oc=5)
- `[19:15]` **🏛️监管 | 骨髓纤维化新希望：CK0804细胞疗法获FDA孤儿药认定，作用机制、临床数据与未来展望** [🔗阅读原文](https://news.google.com/rss/articles/CBMiRkFVX3lxTE9mdXVxN2lUakxacE4yS3VFRWJPc2ItM2dtRFpHWWdmd05DWnh0aUVLN2FQRElJTlJQUFpfa2xuNldfenY2Q1E?oc=5)
- `[18:35]` **循生生物 ReT01 ACT注射液 II期临床启动会顺利召开** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE03Nk1jU0VLQmxJTWdIQkdnek5FUjY1akdYWTU0bEJLazJRRzhMZUxiWld2ckZ5MEloUmQ1em81M2VJZzNrQThCMzJmMDItOUxCREYyNFJXU1YtX2hrdHpFMHMzUm16Mnh6WGhFT0hFZTl6SjlYdDFmRFpmZkRSUQ?oc=5)
- `[14:55]` **博纳吐单抗的设计与开发：BiTE技术先锋，作用机制揭秘、临床应用挑战及与CAR-T的较量** [🔗阅读原文](https://news.google.com/rss/articles/CBMiiwFBVV95cUxNU3Jab0w3Z3dxUG9sZmVXa0V5VzFNYXNvTDExb2E2QjRpQlp1UkJBMHUyU1hucjNNNVRnRlZyTDN0WmwzQ1VHeXVjOWcyR2hCaExpTU9pV0ozeUJDN1BJenNFUkE4SF9CbTI2RGd3LUEwajhDU09STFh4TG1UemVzYmJZSnNfYXMtR2Uw?oc=5)
- `[14:23]` **🔥In-vivo | 来自张江：CGT企业融资7000万美金，并布局双靶in vivo CAR-T** [🔗阅读原文](https://news.google.com/rss/articles/CBMiUkFVX3lxTE93WFdLT3hKLWlWNWJQa3JKazZKRWlXYlEwUzNlTXdYUTJ1QmVJY2Jlcnl6UjFDWnNhcmFCajNIVXpBajc0TThpdWhBUVVXUk1QTHc?oc=5)
- `[13:36]` **【JHO】CD19 CAR-T治疗CNS淋巴瘤失败的模式、风险因素和后续管理-MedSci.cn** [🔗阅读原文](https://news.google.com/rss/articles/CBMibkFVX3lxTE81aTA2RHBXZlJzeFduUzR2WEpuLUdnTjNhUmFldkNQOTFKNzNDd1c1bGFoYzJCZWJEcFJiTm41MGJuTk0xaHlzdXVhWkt6SkdaYTRlOWx0VVl6Q2NoWmVGeFJEMTBvcGF6emw1Ynhn?oc=5)
- `[11:40]` **🔥In-vivo | In Vivo细胞治疗炙手可热，“临床+监管+产业”三方专家提出这八大核心观点** [🔗阅读原文](https://news.google.com/rss/articles/CBMiR0FVX3lxTFBkTkFEa1pwVmRSTTluWE9FX21ZOTlsd19kX01kbTE2M3NlSWQtR2xUVXZ4VHhNLTY4aUJiM1lNMHg2UTR0R0Vr?oc=5)
- `[10:30]` **利多星智投：从载体突破到临床落地，基因治疗的技术革命** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTFA3LW4yVUVEbEFzY0hQU1JHREpyWXk1LUM2eGZQaktHM0ZNUXdlVS1VRFRJRjVtR1lfVUdrQlNGYUdtVldqdnFqejVhU2x3aVRfM0tiMl9YUkI0VTNOU3RTNlpUM00wZkFmZlpOVEllbVBqdzItVktGQy11cUh1UQ?oc=5)
